Congratulations to Awardees of the ASGCT & Pfizer Medical Education Grants!

August 15, 2023

ASGCT and Pfizer grant supports independent medical education for rare disease cell and gene therapies.

ASGCT and Pfizer Global Medical Grants collaborated to offer a competitive grant opportunity focused on supporting medical education to increase the medical and scientific understanding of gene and gene-modified cell therapies.

Through Jan. 30, 2023, organizations submitted RFPs for independent initiatives that could result in measurable improvement in the understanding of therapies spanning multiple rare disease areas. They tailored their projects to members of multidisciplinary care teams for gene and gene-modified cell therapies, including pharmacists, specialty nurses, genetic counselors, medical geneticists, and other physicians.

Join us today in congratulating five outstanding organizations selected to receive funding:

Fondation Maladies Rares—Magda Granata, PhD
Development of a Massive Open Online Training on Gene and Gene-modified Cell Therapies for Rare Diseases

Johns Hopkins University—Todd Dorman, MD
Exploring the Gene Therapy Frontier: From Bench to Bedside

Related Articles


Dr. Terence Flotte Calls for CGT Investment and Collaboration During Congressional Testimony

Read Dr. Flotte's testimony + watch the hearing - February 29, 2024

Mohamed Abou-el-Enein Appointed Editor of Molecular Therapy Methods and Clinical Development

Dr. Abou-el-Enein began five-year term Jan. 1. - January 04, 2024

For Members, ASGCT Has More Programming, Research Funding, and Opportunities Than Ever

Join the largest CGT community - October 03, 2023

Drew Weissman & Katalin Karikó to Co-Receive 2023 Nobel Prize for Discoveries in mRNA Technology

October 02, 2023